Dealcast: The M&amp;A Podcast

Hosted by ION Analytics

Business News

Website RSS feed

Episodes

269

Latest episode

Jun 2026

Language

EN-GB

About the show

Dealcast: The M&A Podcast Weekly podcast from the Mergermarket editorial team covering M&A, ECM and activism presented by Mergermarket

Listen to episodes

60 recent

November 13, 2019Episode 139 min

13: Dealcast: Vertical farming grows up

Could tomorrow’s groceries come from a lab? Today’s vertical-farming startups aim to grow food in tightly controlled indoor stacks, solving a host of problems – blight, water wastage and a shortage of land – at once. Leading the way are such firms as the UK’s Intelligent Growth Solutions, Belgium’s Urban Crop Solutions and Italy’s Planet Farms, all of which featured in recent Mergermarket coverage of the space. Their expansion already offers an investment opportunity for venture capital and private equity, and some early pacesetters, such as Finland’s Netled, are eyeing public listings. Mergermarket’s Barbara Pianese joined us to talk about this intersection of grocery retail, tech and agriculture.

August 9, 2019Episode 1213 min

12: Dealcast: Allergan reaction

The European Commission (EC) is reviewing AbbVie’s [NYSE:ABBV] proposed acquisition of Botox producer Allergan [NYSE:AGN]. The merging parties have already pledged to divest such products as brazikumab, a drug under development for ulcerative colitis and Crohn’s disease, and Zenpep (pancrelipase), which treats a pancreatic disorder, but the EC may want more changes if it is to approve the deal. Dealreporter’s Pablo Mayo Cerqueiro and Mergermarket’s Mintoi Chessa-Florea joined us to discuss how the EC’s review is likely to go.

June 20, 2019Episode 1110 min

11: Dealcast: KKR’s play for Axel Springer

German media conglomerate Axel Springer [ETR:SPR] has caught the eye of KKR [NYSE:KKR]. With Axel Springer’s founding family supporting its bid, KKR has an easier route towards taking the target off the market. Activistmonitor editor William Mace and Mergermarket’s resident DACH expert Emma-Victoria Farr joined us to discuss what the deal could mean for Axel Springer’s future.

June 14, 2019Episode 1015 min

10: Dealreporter Asia: AGL Energy's offer for Vocus, Healius' investing in Japan and Kuyushu Railway Co's AGM

In this weekly edition of Dealreporter Asia Pacific’s podcast, Anette Jönsson and Ed Vinales discuss key deals and developments relevant to Asia event-driven investors, including AGL Energy’s [ASX:AGL] new indicative offer for Australian telecom company Vocus [ASX:VOC], private equity interest in Australian healthcare provider Healius [ASX:ALS] and corporate governance-related investing in Japan. In connection with the latter we highlight the upcoming AGM for Kyushu Railway Co [TYO:9142] that will feature a number of proposals from an activist investor. We also touch on the possible implications for the Chinese ADR delist/relist trend of US Senator Marco Rubio’s recent move to introduce a bill that proposes to delist US-listed Chinese companies that don’t open their audit books to US regulators, and discuss why the bill may have legs and could become legislation.   

May 31, 2019Episode 918 min

9: Dealcast Asia: Melco buys Crown stake, Qunar's surprise ruling

In this weekly edition of Dealreporter Asia Pacific’s podcast, Stephanie Hanna and Anette Jönsson discuss key developments on several Asian situations, including comments by Malaysia’s prime minister indicating Australian rare earth producer Lynas [ASX:LYC] will be allowed to continue operating in the Southeast Asian country; and the potential implications of casino tycoon James Packer selling part of his stake in Crown Resorts [ASX:CWN] to Melco Resorts & Entertainment [NASDAQ:MLCO] less than two months after his talks with Wynn Resorts [NASDAQ:WYNN] were terminated following a leak. At the end of the podcast we reveal an unexpected judicial setback for the dissenting shareholders of Qunar’s take-private that could have implications for ongoing and future Section 238 fair value processes in Cayman.

October 13, 2020Episode 827 min

8: Tipping Point: Deal Terms

Seyfarth’s Paul Pryzant and SRS Acquiom's Chris Letang join Tom Cane to discuss how the shift from a seller’s to a buyer’s M&A market this year has impacted the deal terms being agreed in the mid-market, from an increase in earn-outs and termination fees to the impact of the pandemic on reps and warranties. Paul and Chris also discuss how technology is changing the due diligence process.

May 29, 2019Episode 89 min

8: Dealcast: Tech listings go awry

Wobbly tech-sector IPOs, including those of Uber [NYSE:UBER] and Finablr [LON:FIN], have dampened the mood for ECM. Dealreporter ECM editor Gustav Sandstrom joined us to discuss how these high-profile fumbles could affect similar listings ahead this year.

March 30, 2021Episode 820 min

The European SPACs boom and SS&C Intralinks Deal Flow Predictor

The SS&C Intralinks Deal Flow Predictor provides a six-month view of global and regional M&A activity and a wealth of actionable market intelligence. Read the latest edition of the SS&C Intralinks Deal Flow Predictor to find out the data-driven M&A forecast for the next six months, by region and globally. This edition also features:• A spotlight feature, “Breaking Up Big Tech,” charting regulators’ new antitrust fervor• An interview with Raquel Perez Martinez, Executive Investments and M&A Director for Europe and Brazil at EDP Renováveis (EDPR), on the charging up of renewable energyDownload the latest issue today.https://www.intralinks.com/insights/publication/deal-flow-predictor-2021q2

April 29, 2020Episode 718 min

7: Dealcast: Covid-19 and healthcare M&A

No sector is closer than healthcare to the front-lines of the covid-19 pandemic. Not only is the pandemic shaking up businesses in the sector, it is creating opportunities for dealmaking. Indeed, Thermo Fisher’s [NYSE:TMO] proposed takeover of diagnostics firm Qiagen [NYSE:QGEN] shows how the crisis can make the case for M&A. In this week’s podcast, Mergermarket healthcare editor Mintoi Chessa-Florea, Mergermarket healthcare reporter Davide Salvi and Dealreporter analyst William Cain join us to discuss the sector. At issue are: pre-covid-19 M&A trends, the effect of the pandemic on business cases, the effect of the pandemic on M&A and ECM, and the outlook for Qiagen/Thermo Fisher.

May 24, 2019Episode 712 min

7: Dealcast Asia: SAMR leadership change, the latest on Lynas and upcoming deals

In this inaugural edition of Dealreporter Asia Pacific’s podcast, Stephanie Hanna and Ed Vinales discuss the appointment of a new head of China’s State Administration for Market Regulation (SAMR), and how the US-China trade dispute is impacting Wesfarmer’s hostile bid for rare-earth miner Lynas. Other situations covered include the hairy privatisation of Hong Kong’s Harbin Electric, and the ongoing sale processes surrounding Hitachi Chemical, and NXC Corp, which owns 47.68% of South Korea’s largest gaming company Nexon. The journalists end the podcast discussing why Australian development and construction business Lendlease could become a takeover target.  